Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007)
Clinical trial NCT01341639 · COMPLETED
Trial details
- NCT number
- NCT01341639
- Sponsor
- MCM Vaccines B.V.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-26
- Primary completion
- 2013-03-13
- Enrollment
- 1250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.